HIGHLIGHTS OF PRESCRIBING INFORMATIONThese highlights do not include all the... |

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
doxercalciferol injection
If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.
doxercalciferol injection Quick Finder
1 INDICATIONS AND USAGE
Doxercalciferol Injection is indicated for the treatment of secondary hyperparathyroidism in adult patients with chronic kidney disease (CKD) on dialysis.
2 DOSAGE AND ADMINISTRATION
2.1 Prior to Initiation of Doxercalciferol Injection
- Ensure serum calcium is not above the upper limit of normal before initiating...
3 DOSAGE FORMS AND STRENGTHS
Injection: clear and colorless solution available as follows:
- 4 mcg/2 mL (2 mcg/mL) multiple-dose 2 mL vial
- 10 mcg/5 mL (2 mcg/mL) multiple-dose 5 mL vial ...
4 CONTRAINDICATIONS
Doxercalciferol Injection is contraindicated in patients with:
- Hypercalcemia [see Warnings and Precautions (5.1)]
- Vitamin D...
5 WARNINGS AND PRECAUTIONS
5.1 Hypercalcemia
Hypercalcemia may occur during Doxercalciferol Injection treatment. Acute hypercalcemia may increase the risk of cardiac...
6 ADVERSE REACTIONS
The following adverse reactions are discussed in greater detail in another section of the label:
- Hypercalcemia [see Warnings and Precautions (...
7 DRUG INTERACTIONS
Table 2 includes clinically significant drug interactions with doxercalciferol.
8 USE IN SPECIFIC POPULATIONS
8.1 Pregnancy
Risk Summary
The limited available...
10 OVERDOSAGE
Overdosage of Doxercalciferol Injection may lead to hypercalcemia, hypercalciuria, and hyperphosphatemia [see Warnings and Precautions (5.1)]. The treatment of...
11 DESCRIPTION
Doxercalciferol is a synthetic vitamin D2 analog. Doxercalciferol undergoes metabolic activation in vivo to form 1α,25-dihydroxyvitamin D...
12 CLINICAL PHARMACOLOGY
12.1 Mechanism of Action
Doxercalciferol is a synthetic vitamin D2 analog that requires metabolic activation to form...
13 NONCLINICAL TOXICOLOGY
13.1 Carcinogenesis, Mutagenesis, Impairment of Fertility
In a 104-week carcinogenicity study in rats, there was an increased incidence of...
14 CLINICAL STUDIES
The safety and efficacy of Doxercalciferol Injection have been established based on adult studies of doxercalciferol injection in patients with CKD on hemodialysis. Below is a display of the results of...
16 HOW SUPPLIED/STORAGE AND HANDLING
Doxercalciferol Injection is a clear, colorless solution in multiple-dose amber glass vials supplied as follows:
17 PATIENT COUNSELING INFORMATION
Hypercalcemia
Advise patients to contact a health care provider if they develop symptoms of elevated...
To report an adverse event related to Pfizer-BioNTech COVID-19 Vaccine (also known as COMIRNATY®, COVID-19 mRNA, Vaccine BNT162b2 or BNT162) or Pfizer COVID-19 Treatment (also known as PAXLOVID™ (nirmatrelvir tablets; ritonavir tablets)), and you are not part of a clinical trial* for this product, click the link below to submit your information:
*If you are involved in a clinical trial for either product, adverse events should be reported to your coordinating study site.
If you cannot use the above website or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at(800) 438-1985.
(800)-332-1088.